SB 136

  • Indiana Senate Bill
  • 2025 Regular Session
  • Introduced in Senate
  • Senate
  • House
  • Governor

Disclosures related to prescription drugs.

Abstract

Beginning January 1, 2026, requires a state employee health plan, a policy of accident and sickness insurance, and a health maintenance organization contract to provide to a covered individual the national average drug acquisition cost of a generic drug on the written materials provided at the point of sale. Provides that if an agreement between a health plan and a pharmacy benefit manager that is entered into or renewed after December 31, 2025, provides that less than 85% of the estimated rebates will be deducted from the cost of prescription drugs before a covered individual's cost sharing requirement is determined, the pharmacy benefit manager must provide the policyholder with a notice on an annual basis that includes: (1) an explanation of what a rebate is; (2) an explanation of how rebates accrue to the health plan from the manufacturer; and (3) the aggregate amount of rebates that accrued to the health plan for prescription drugs dispensed under the policyholder's health plan for the previous year.

Bill Sponsors (1)

Votes


No votes to display

Actions


Jan 08, 2025

Senate

First reading: referred to Committee on Health and Provider Services

  • Reading-1
  • Referral-Committee
Health and Provider Services

Senate

Authored by Senator Bohacek

Bill Text

Bill Text Versions Format
Introduced Senate Bill (S) PDF

Related Documents

Document Format
Fiscal Note: SB0136.01.INTR.FN001 PDF

Sources

Data on Open States is updated periodically throughout the day from the official website of the Indiana General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.